Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Etonorgestrel- and levonorgestrel-releasing implants lower ulna bone density
March 9th, 2006
Etonorgestrel- and levonorgestrel-releasing contraceptive implant use is associated with reduced bone density at the ulna. A group of scientists in Brazil conducted a study "to compare bone mineral density (BMD) before insertion and at 18 months of use of etonorgestrel- and levonorgestrel-releasing contraceptive implants." "One hundred and eleven women, 19-43 years of age, were randomly allocated to two groups: 56 to etonorgestrel and 55 to levonorgestrel," explained L. Bahamondes and coauthors at the State University of Campinas in Sao Paulo. "BMD was evaluated at the midshaft of the ulna and at the distal radius of the...
Source: Women's Health Weekly (2006-03-09)
|
